Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.

By L. Poirel, P. Nordmann. Clinical Microbiology and Infection, 2006

1,118 citations recorded by the source corpus.

Subfields: Endocrinology, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/7f372089ea937174af685def2d104c38e40a4667

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology

1. L. Poirel
2. P. Nordmann
3. Robert A. Bonomo
4. David L. Paterson
5. A. Potron
6. Sarah M. Drawz
7. H. Seifert
8. Anton Y. Peleg

In Molecular Medicine

1. P. Nordmann
2. L. Poirel
3. Robert A. Bonomo
4. David L. Paterson
5. A. Potron
6. Sarah M. Drawz
7. H. Seifert
8. E. Kaleta

In Pharmacology

1. P. Nordmann
2. L. Poirel
3. H. Seifert
4. Robert A. Bonomo
5. David L. Paterson
6. D. Livermore
7. Sarah M. Drawz

Citations in the corpus

• Bacterial Antibiotic Resistance: The Most Critical Pathogens (2021, background): “Class C β-lactamases are a group of broadly disseminated enzymes usually resistant to cephamycins (cefoxitin and cefotetan), penicillins and cephalosporins [32,33].”
• Three Decades of β-Lactamase Inhibitors (2010, background): “Resistance to imipenem and meropenem has also been associated with the loss of the CarO OMP in clinical isolates of multidrug-resistant Acinetobacter baumannii (278, 346).”
• Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology (2013, background): “Carbapenem-resistant Acinetobacter baumannii is a concern for clinicians, as it drastically limits options for antibiotic intervention (330).”
• Antimicrobial Resistance in ESKAPE Pathogens (2020, background): “baumannii PBPs can also contribute to carbapenem resistance (186).”
• An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii (2007, background): “baumannii to a particular group of antibiotics can best be illustrated by the mechanisms that are associated with carbapenem resistanc”
• Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. (2015, background): “baumannii; when identified, they are either IMP-like, VIM-like, SIM-1 or NDM-like enzymes [107].”
• Global Challenge of Multidrug-Resistant Acinetobacter baumannii (2007, background): “baumannii; it has been found in isolates from four continents, and its expression varies according to the presence of ISAba1, as previously discussed (152).”
• Acinetobacter baumannii: Emergence of a Successful Pathogen (2008, background): “baumannii (443), the contributions of the acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance are often difficult to determine.”
• Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. (2011, background): “These genes may be chromosomally or plasmid encoded (Poirel & Nordmann, 2006) (Higgins et al., 2010b) (Mugnier et al., 2010).”